OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
HbA1c Variability and Cardiovascular Events in Patients with Prostate Cancer Receiving Androgen Deprivation Therapy
Jeffrey Shi Kai Chan, Yan Hiu Athena Lee, Kang Liu, et al.
European Urology Open Science (2022) Vol. 47, pp. 3-11
Open Access | Times Cited: 7
Jeffrey Shi Kai Chan, Yan Hiu Athena Lee, Kang Liu, et al.
European Urology Open Science (2022) Vol. 47, pp. 3-11
Open Access | Times Cited: 7
Showing 7 citing articles:
Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology
Darren M.C. Poon, G M Tan, Kuen Chan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Darren M.C. Poon, G M Tan, Kuen Chan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
PowerAI-Diabetes: Review of glycemic and lipid variability to predict cardiovascular events in Chinese diabetic population
Sharen Lee, Tong Liu, Cheuk To Chung, et al.
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Sharen Lee, Tong Liu, Cheuk To Chung, et al.
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Comprehensive review of cardiovascular disease in prostate cancer: epidemiology, risk factors, therapeutics and prevention strategies
Joseph Moryousef, Wilhelmina Duivenvoorden, Darryl P. Leong, et al.
Prostate Cancer and Prostatic Diseases (2024)
Closed Access | Times Cited: 1
Joseph Moryousef, Wilhelmina Duivenvoorden, Darryl P. Leong, et al.
Prostate Cancer and Prostatic Diseases (2024)
Closed Access | Times Cited: 1
Cardiovascular disease burden in patients with urological cancers: The new discipline of uro‐cardio‐oncology
Yi Zheng, Ying Liu, Ziliang Chen, et al.
Cancer Innovation (2024) Vol. 3, Iss. 2
Open Access
Yi Zheng, Ying Liu, Ziliang Chen, et al.
Cancer Innovation (2024) Vol. 3, Iss. 2
Open Access
Serum glycosylated hemoglobin and prostate cancer risk: Results from a systematic review and dose-response meta-analysis
Mengqi Li, Jingqiang Huang, Wenwen Lu, et al.
Urologic Oncology Seminars and Original Investigations (2024)
Closed Access
Mengqi Li, Jingqiang Huang, Wenwen Lu, et al.
Urologic Oncology Seminars and Original Investigations (2024)
Closed Access
Efficacy of metformin drug in preventing metabolic syndrome associated with androgen deprivation therapy (ADT) in prostate cancer patients: A systematic review and meta-analysis
Ibrahim Abdelnasar Yakout, Mohamed Mustafa Gallab, Dahiya Mohamed, et al.
Seminars in Oncology (2024) Vol. 51, Iss. 5-6, pp. 163-174
Closed Access
Ibrahim Abdelnasar Yakout, Mohamed Mustafa Gallab, Dahiya Mohamed, et al.
Seminars in Oncology (2024) Vol. 51, Iss. 5-6, pp. 163-174
Closed Access
ChineseCVD: first-in-world, web-based, Chinese-specific Cardiovascular Risk Calculator incorporating long COVID, COVID-19 vaccination, SGLT2i and PCSK9i treatment effects
Carlin Chang, Gary Tse, Quinncy Lee, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Carlin Chang, Gary Tse, Quinncy Lee, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
